West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. Total Liabilities 2008–2025
West Pharmaceutical Services, Inc. annual/quarterly total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- West Pharmaceutical Services, Inc. total liabilities for the quarter ending December 31, 2025 were 1.09B, a 13.83% increase year-over-year.
- West Pharmaceutical Services, Inc. total liabilities for 2025 were 1.09B, a 13.83% increase from 2024.
- West Pharmaceutical Services, Inc. total liabilities for 2024 were 961.1M, a 1.33% increase from 2023.
- West Pharmaceutical Services, Inc. total liabilities for 2023 were 948.5M, a 1.78% increase from 2022.
- West Pharmaceutical Services, Inc. total liabilities for 2022 were 931.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| West Pharmaceutical Services, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1,094 |
| 2024 | $961 |
| 2023 | $949 |
| 2022 | $932 |
| 2021 | $978 |
| 2020 | $939 |
| 2019 | $768 |
| 2018 | $583 |
| 2017 | $583 |
| 2016 | $599 |
| 2015 | $671 |
| 2014 | $713 |
| 2013 | $765 |
| 2012 | $835 |
| 2011 | $744 |
| West Pharmaceutical Services, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $1,094 |
| 2024-12-31 | $961 |
| 2023-12-31 | $949 |
| 2022-12-31 | $932 |
| 2021-12-31 | $978 |
| 2020-12-31 | $939 |
| 2019-12-31 | $768 |
| 2018-12-31 | $583 |
| 2017-12-31 | $583 |
| 2016-12-31 | $599 |
| 2015-12-31 | $671 |
| 2014-12-31 | $713 |
| 2013-12-31 | $765 |
| 2012-12-31 | $835 |
| 2011-12-31 | $744 |
| 2010-12-31 | $669 |
| 2009-12-31 | $692 |
West Pharmaceutical Services, Inc. Total Liabilities — FAQ
West Pharmaceutical Services, Inc. (WST) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WST's total liabilities history?
The chart and table above show West Pharmaceutical Services, Inc.'s total liabilities by year and by quarter, including the growth rate.